查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2058595

體外診斷實驗室自動化市場：依產品類型、應用、流程、最終用戶、國家及地區分類－全球產業分析、市場規模、市場佔有率及2026年至2033年預測

Lab Automation for In-Vitro Diagnostics Market, By Product Type, By Application, By Process Type, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 366 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，體外診斷實驗室自動化市場規模將達到 60.52 億美元，從 2026 年到 2033 年將以 7.3% 的複合年成長率成長。

體外診斷實驗室自動化是指利用自動化設備、機器人系統、軟體平台和數位化工作流程，最大限度地減少臨床檢測中的人工操作。這些系統能夠以更有系統、更有效率的方式管理樣本製備、檢測、數據記錄和結果分析等任務。自動化技術廣泛應用於醫院、診斷中心和實驗室，以提高檢測的一致性、減少操作延遲並支援大規模臨床檢測。它還能幫助醫療專業人員在各種醫療環境中更快地提供診斷訊息，用於疾病檢測、患者監測和治療方案製定。

隨著全球醫療衛生系統不斷加強檢查室基礎設施和數位化醫療服務，體外診斷檢查室自動化市場正穩步成長。美國食品藥物管理局(FDA) 持續擴展其關於體外診斷、檢查室軟體驗證和互聯醫療系統的監管指南，以支援安全可靠的自動化檢測環境。世界衛生組織 (WHO) 指出，診斷服務影響約 70% 的醫療決策，並鼓勵各國實現檢測操作現代化，提高高品質診斷服務的可近性。亞太地區和中東各國政府也正在增加對智慧醫院、分子檢測設施和檢查室數位化專案的投資，推動自動化分析儀、機器人檢體處理系統和整合檢測工作流程技術的全球應用。

體外診斷實驗室自動化市場－市場動態

對速度更快、檢測量更大的診斷測試的需求不斷成長，正在推動市場擴張。

隨著醫療系統需要處理大量患者檢體和進行複雜的檢測流程，對更快、更有效率的診斷檢測的需求日益成長，這成為體外診斷檢查室自動化市場的主要驅動力。檢查室正擴大採用自動化分析儀、機器人檢體處理系統和數位化工作流程平台，以減少人工工作量並提高檢測效率。世界衛生組織（WHO）指出，診斷結果影響約70%的醫療決策，這凸顯了可靠及時的檢測服務的重要性日益凸顯。

在亞洲和其他醫療衛生發展中地區，各國正在加強檢測基礎設施建設，並擴大分子和傳染病檢查項目的覆蓋範圍。羅氏和雅培等公司正在部署自動化診斷平台和整合檢測系統，以支援更快速的臨床檢測和大規模檢體管理。在對準確、擴充性和連續檢測日益成長的需求驅動下，醫院和診斷中心正在利用自動化體外診斷技術對其檢查室進行現代化改造。

體外診斷檢查室自動化市場－市場細分分析：

全球體外診斷實驗室自動化市場按產品類型、應用、製程類型、最終用戶和地區進行細分。

依產品類型分類，市場可分為五類。在對快速、準確和高通量臨床檢測需求不斷成長的推動下，自動化分析儀在體外診斷實驗室自動化市場中發揮著至關重要的作用。醫療檢查室面臨持續的壓力，需要在減少人工操作和保持檢測一致性的同時處理更多患者檢體。自動化分析儀透過整合檢體處理、提高處理速度數位資料管理，有助於提升檢查室工作流程效率。羅氏等公司正在推動互聯分析儀系統和智慧檢查室自動化平台的發展，以支援分子診斷、免疫檢測和臨床化學檢測。產業報告也指出，隨著檢查室實現營運現代化以管理複雜的診斷任務並減少檢測環境中的人為錯誤，自動化液體處理和分析儀技術的應用正在不斷擴展。對標準化診斷工作流程的需求不斷成長、檢測量不斷增加以及數位醫療基礎設施的普及，正促使醫院和診斷中心投資於先進的自動化分析儀系統，用於常規和特殊檢測應用。

體外診斷實驗室自動化市場—區域洞察

在全球區域展望中，受實驗室基礎設施現代化和先進診斷服務普及的推動，亞太地區的體外診斷檢查室自動化市場預計將實現顯著成長。各國政府正大力支持數位化醫療計畫、智慧醫院系統和檢查室標準化舉措，以提高檢測效率和患者照護。中國正成為這一趨勢的關鍵國家，不斷增加對自動化臨床檢查室、感染疾病監測和精準醫療計畫的投資。中國正透過醫療現代化政策和數位化醫院網路的擴張，推動智慧醫療技術的應用。邁瑞、希森美康和法邦等公司正致力於提升自動化分析儀、機器人檢體處理系統和智慧檢查室平台的效能，以滿足醫院和診斷中心日益成長的檢測需求。世界衛生組織（WHO）指出，診斷檢測影響約70%的醫療決策，許多國家仍在努力擴大可靠檢測系統和必要診斷檢測的普及範圍。同時，美國食品藥物管理局（FDA）持續加強對體外診斷醫療設備、檢查室開發測試、軟體驗證和電子實驗室數據整合等方面的監管指導，敦促全球製造商提高自動化品質和工作流程的可靠性。這些措施正推動亞太地區的醫療機構、研究機構和檢查室營運商採用擴充性的、數位化連接的檢查室自動化技術，以提供更快捷、更標準化的診斷檢測服務。

韓國體外診斷檢測自動化市場—國家概況

韓國正透過持續投資數位醫療基礎設施、人工智慧診斷和智慧醫院項目，不斷鞏固其在自動化體外診斷檢測領域的地位。韓國保健福祉部和科學技術資訊通訊部正透過「AX-Sprint」宣傳活動，支援人工智慧主導的醫療技術商業化。 「AX-Sprint」計畫為臨床檢驗和醫院系統整合專案提供資金支援。韓國政府近期宣布，計劃在2032年投資約9,400億韓元用於先進醫療設備的研發。此外，Seegene、Sysmex Corporation和三星醫療中心等公司正積極參與自動化分子診斷和檢測資料整合技術的推廣應用。韓國正在建立安全的醫療數據共用平台和人工智慧專用醫院網路，以實現醫療機構工作流程的自動化，並提高診斷準確性。政府主導的「Doctor Answer 2.0」等項目，透過醫院與資訊通訊技術公司之間的合作，支持多疾病人工智慧醫療軟體的開發。這些發展正在加速全國範圍內聯網自動化診斷檢查室的引入。

目錄

第1章：體外診斷實驗室自動化市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：體外診斷實驗室自動化的關鍵市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：體外診斷實驗室自動化產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：體外診斷實驗室自動化市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：體外診斷實驗室自動化市場趨勢

  • 體外診斷實驗室自動化市場佔有率分析（2025 年）
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 體外診斷實驗室自動化市場：依產品類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按產品類型
    • 自動分析儀
    • 液體處理系統
    • 實驗室機器人
    • 樣品製備系統
    • 資料管理軟體

第8章 體外診斷實驗室自動化市場：依應用領域分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 臨床化學
    • 免疫檢測
    • 微生物學
    • 血液學
    • 分子診斷
    • 其他

第9章 體外診斷實驗室自動化市場：依製程類型分類

  • 概述
    • 細分市場佔有率分析：流程類型
    • 預分析自動化
    • 分析自動化
    • 分析後自動化
    • 整合工作流程自動化
    • 檢體的追蹤與存儲

第10章 體外診斷實驗室自動化市場：依最終使用者分類

  • 概述
    • 基於細分市場的市場佔有率分析：按最終用戶分類
    • 醫院
    • 診斷檢查室
    • 學術研究機構
    • 生技公司
    • 藥物研究所
    • 其他

第11章 體外診斷實驗室自動化市場：按地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第12章：主要供應商分析：體外診斷實驗室自動化產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Roche
    • Abbott
    • Siemens Healthineers
    • Danaher Corporation
    • Thermo Fisher Scientific
    • Becton Dickinson and Company
    • Agilent Technologies
    • Bio-Rad Laboratories
    • QIAGEN
    • Tecan Group
    • PerkinElmer
    • Hamilton Company
    • Illumina
    • Sysmex Corporation
    • Hudson Robotics
    • Aurora Biomed
    • Eppendorf
    • Beckman Coulter
    • Shimadzu Corporation
    • Revvity
    • Others

第13章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV6569

Lab Automation for In-Vitro Diagnostics Market size was valued at US$ 6,005.2 Million in 2025, expanding at a CAGR of 7.3% from 2026 to 2033.

Lab Automation for In-Vitro Diagnostics refers to the use of automated instruments, robotic systems, software platforms, and digital workflows to perform laboratory diagnostic testing with limited manual handling. These systems help laboratories manage activities such as sample preparation, testing, data recording, and result analysis in a more organized and efficient manner. Automation is widely used in hospitals, diagnostic centers, and research laboratories to improve testing consistency, reduce operational delays, and support large-scale clinical testing. It also assists healthcare professionals in delivering faster diagnostic information for disease detection, patient monitoring, and treatment planning across different healthcare settings.

The Lab Automation for In-Vitro Diagnostics market is developing steadily as healthcare systems worldwide continue strengthening laboratory infrastructure and digital healthcare services. The U.S. Food and Drug Administration continues expanding regulatory guidance for in-vitro diagnostics, laboratory software validation, and connected healthcare systems to support safe and reliable automated testing environments. The World Health Organization states that diagnostic services influence nearly 70% of healthcare decisions, encouraging countries to modernize laboratory operations and improve access to quality diagnostics. Governments across Asia-Pacific and the Middle East are also increasing investment in smart hospitals, molecular testing facilities, and laboratory digitalization programs, supporting broader adoption of automated analyzers, robotic sample handling systems, and integrated laboratory workflow technologies worldwide.

Lab Automation for In-Vitro Diagnostics Market- Market Dynamics

Rising demand for faster and high-volume diagnostic testing supporting market expansion

The Increasing demand for faster and high-volume diagnostic testing has become a key factor in the Lab Automation for In-Vitro Diagnostics market, as healthcare systems manage large volumes of patient samples and complex laboratory procedures. Laboratories are increasingly adopting automated analyzers, robotic sample handling systems, and digital workflow platforms to reduce manual workload and improve testing efficiency. The World Health Organization states that diagnostic results influence nearly 70% of healthcare decisions, highlighting the growing importance of reliable and timely laboratory services.

Countries across Asia and other developing healthcare regions are strengthening laboratory infrastructure and expanding access to molecular and infectious disease testing programs. Companies such as Roche and Abbott are expanding automated diagnostic platforms and integrated laboratory systems to support faster clinical testing and large-scale sample management. Increasing demand for accurate, scalable, and continuous testing operations is encouraging hospitals and diagnostic centers to modernize laboratories with automated in-vitro diagnostic technologies.

Lab Automation for In-Vitro Diagnostics Market- Segmentation Analysis:

The Global Lab Automation for In-Vitro Diagnostics Market is segmented on the basis of Product Type, Application, Process Type, End User, and Region.

Under product type categories, the market varies into five types. Automated analyzers designate its participation in the Lab Automation for In-Vitro Diagnostics market due to the increasing demand for rapid, accurate, and high-volume clinical testing. Healthcare laboratories are under continuous pressure to process larger numbers of patient samples while maintaining testing consistency and reducing manual intervention. Automated analyzers help laboratories improve workflow efficiency through integrated sample handling, faster processing, and digital data management. Companies such as Roche are strengthening connected analyzer systems and intelligent laboratory automation platforms to support molecular diagnostics, immunoassays, and clinical chemistry testing. Industry reports also indicate growing adoption of automated liquid handling and analyzer technologies as laboratories modernize operations to manage complex diagnostic workloads and reduce human error in testing environments. Increasing demand for standardized diagnostic workflows, rising laboratory testing volumes, and broader adoption of digital healthcare infrastructure are encouraging hospitals and diagnostic centers to invest in advanced automated analyzer systems for routine and specialized testing applications.

Lab Automation for In-Vitro Diagnostics Market- Geographical Insights

From a global regional outlook, Asia-Pacific is forecasted to register meaningful growth in the Lab Automation for In-Vitro Diagnostics market as healthcare systems across the region continue modernizing laboratory infrastructure and expanding access to advanced diagnostic services. Governments are supporting digital healthcare programs, intelligent hospital systems, and laboratory standardization initiatives to improve testing efficiency and patient care. China is emerging as an important country within this development due to rising investment in automated clinical laboratories, infectious disease surveillance, and precision medicine programs. The country is encouraging adoption of smart healthcare technologies through healthcare modernization policies and expansion of digital hospital networks. Companies such as Mindray, Sysmex Corporation, and Fapon are strengthening automated analyzers, robotic sample handling systems, and intelligent laboratory platforms to support growing testing requirements across hospitals and diagnostic centers. The World Health Organization states that nearly 70% of healthcare decisions are influenced by diagnostic testing, while many countries are still expanding access to reliable laboratory systems and essential diagnostics. In parallel, the U.S. Food and Drug Administration continues strengthening regulatory guidance for in-vitro diagnostics, laboratory-developed tests, software validation, and electronic laboratory data integration, encouraging global manufacturers to improve automation quality and workflow reliability. These developments are encouraging healthcare providers, research institutions, and laboratory operators across the Asia-Pacific to adopt scalable and digitally connected laboratory automation technologies for faster and more standardized diagnostic testing services

South Korea Lab Automation for In-Vitro Diagnostics Market- Country Insights

South Korea is strengthening its position in laboratory automation for in-vitro diagnostics through continued investment in digital healthcare infrastructure, AI-supported diagnostics, and smart hospital programs. The ministries of Health and Welfare and Science and ICT have been backing the commercialization efforts on AI technology-driven healthcare technologies via AX-Sprint campaign. The AX-Sprint program provides funding support to clinical validation and hospital system-integration projects. The Korean government recently revealed that it plans to spend around 940 billion won on the research and development of advanced medical devices until 2032. The country is also witnessing active participation from companies such as Seegene, Sysmex Corporation, and Samsung Medical Center in expanding automated molecular diagnostics and laboratory data integration technologies. South Korea is building secure medical data-sharing platforms and AI-specialized hospital networks to improve workflow automation and diagnostic accuracy across healthcare institutions. Government-backed projects such as Doctor Answer 2.0 are supporting development of AI medical software for multiple diseases through collaborations involving hospitals and ICT firms. These developments are encouraging broader adoption of connected and automated diagnostic laboratories throughout the country.

Lab Automation for In-Vitro Diagnostics Market- Competitive Landscape:

In response to the rising need for faster diagnostic turnaround, digital laboratory supervision, and high-throughput testing, companies operating in the Lab Automation for In-Vitro Diagnostics market are firming their technological abilities through automation upgrades, software integration, and strategic associations. Roche, Abbott, Siemens Healthineers, Danaher Corporation, and Labcorp are some of the key players who have implemented automated analyzers, AI-based laboratory testing systems, and integrated diagnostic devices to enhance workflow accuracy and sample handling efficiency.

In 2025, Siemens expanded its laboratory software capabilities through the acquisition of Dotmatics, while Abbott announced the acquisition of Exact Sciences to strengthen automated molecular diagnostics and oncology testing solutions. Companies are also investing in robotic sample handling, cloud-based laboratory data systems, and integrated testing platforms to support hospitals, clinical laboratories, and research institutions seeking efficient and standardized diagnostic operations.

Recent Developments:

In January 2026, Thermo Fisher Scientific announced a strategic collaboration with NVIDIA to advance AI-enabled scientific instruments and improve laboratory automation performance in diagnostics and research facilities. The collaboration strengthened AI-driven laboratory automation capabilities, supporting faster diagnostics, smarter workflows, and improved operational efficiency in research laboratories.

In October 2025, ARCHIMED Diagnostics finalized the acquisition of ARK Diagnostics to support expansion in automated immunoassay testing and therapeutic drug monitoring solutions. The acquisition expanded automated diagnostic testing capabilities, enhancing therapeutic monitoring efficiency and supporting broader adoption of advanced immunoassay technologies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LAB AUTOMATION FOR IN-VITRO DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Roche
  • Abbott
  • Siemens Healthineers
  • Danaher Corporation
  • Thermo Fisher Scientific
  • Becton Dickinson and Company
  • Agilent Technologies
  • Bio-Rad Laboratories
  • QIAGEN
  • Tecan Group
  • PerkinElmer
  • Hamilton Company
  • Illumina
  • Sysmex Corporation
  • Hudson Robotics
  • Aurora Biomed
  • Eppendorf
  • Beckman Coulter
  • Shimadzu Corporation
  • Revvity
  • Others

GLOBAL LAB AUTOMATION FOR IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033

  • Automated Analyzers
  • Liquid Handling Systems
  • Laboratory Robotics
  • Sample Preparation Systems
  • Data Management Software

GLOBAL LAB AUTOMATION FOR IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Clinical Chemistry
  • Immunoassay
  • Microbiology
  • Hematology
  • Molecular Diagnostics
  • Others

GLOBAL LAB AUTOMATION FOR IN-VITRO DIAGNOSTICS MARKET, BY PROCESS TYPE- MARKET ANALYSIS, 2020 - 2033

  • Pre-Analytical Automation
  • Analytical Automation
  • Post-Analytical Automation
  • Integrated Workflow Automation
  • Sample Tracking & Storage

GLOBAL LAB AUTOMATION FOR IN-VITRO DIAGNOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Hospitals
  • Diagnostic Laboratories
  • Academic & Research Institutes
  • Biotechnology Companies
  • Pharmaceutical Laboratories
  • Others

GLOBAL LAB AUTOMATION FOR IN-VITRO DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Lab Automation for In-Vitro Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Lab Automation for In-Vitro Diagnostics Market Snippet by Product Type
    • 2.1.2. Lab Automation for In-Vitro Diagnostics Market Snippet by Application
    • 2.1.3. Lab Automation for In-Vitro Diagnostics Market Snippet by Process Type
    • 2.1.4. Lab Automation for In-Vitro Diagnostics Market Snippet by End User
    • 2.1.5. Lab Automation for In-Vitro Diagnostics Market Snippet by Country
    • 2.1.6. Lab Automation for In-Vitro Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Lab Automation for In-Vitro Diagnostics Key Market Trends

  • 3.1. Lab Automation for In-Vitro Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Lab Automation for In-Vitro Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Lab Automation for In-Vitro Diagnostics Market Opportunities
  • 3.4. Lab Automation for In-Vitro Diagnostics Market Future Trends

4. Lab Automation for In-Vitro Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Lab Automation for In-Vitro Diagnostics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Lab Automation for In-Vitro Diagnostics Market Landscape

  • 6.1. Lab Automation for In-Vitro Diagnostics Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Lab Automation for In-Vitro Diagnostics Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
    • 7.1.2. Automated Analyzers
    • 7.1.3. Liquid Handling Systems
    • 7.1.4. Laboratory Robotics
    • 7.1.5. Sample Preparation Systems
    • 7.1.6. Data Management Software

8. Lab Automation for In-Vitro Diagnostics Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Clinical Chemistry
    • 8.1.3. Immunoassay
    • 8.1.4. Microbiology
    • 8.1.5. Hematology
    • 8.1.6. Molecular Diagnostics
    • 8.1.7. Others

9. Lab Automation for In-Vitro Diagnostics Market - By Process Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Process Type, 2025 & 2033 (%)
    • 9.1.2. Pre-Analytical Automation
    • 9.1.3. Analytical Automation
    • 9.1.4. Post-Analytical Automation
    • 9.1.5. Integrated Workflow Automation
    • 9.1.6. Sample Tracking & Storage

10. Lab Automation for In-Vitro Diagnostics Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Diagnostic Laboratories
    • 10.1.4. Academic & Research Institutes
    • 10.1.5. Biotechnology Companies
    • 10.1.6. Pharmaceutical Laboratories
    • 10.1.7. Others

11. Lab Automation for In-Vitro Diagnostics Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Lab Automation for In-Vitro Diagnostics Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Lab Automation for In-Vitro Diagnostics Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.17. Denmark
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.17.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.17.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.17.5. Denmark Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.3.17.6. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.18. Rest of Europe
      • 11.3.18.1. Overview
      • 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.18.5. Rest of the Europe Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.3.18.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Lab Automation for In-Vitro Diagnostics Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.16. Taiwan
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.16.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.16.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.16.5. Taiwan Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.4.16.6. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.17. Vietnam
      • 11.4.17.1. Overview
      • 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.17.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.17.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.17.5. Vietnam Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.4.17.6. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.18. Rest of APAC
      • 11.4.18.1. Overview
      • 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.18.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.18.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.18.5. Rest of APAC Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.4.18.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Lab Automation for In-Vitro Diagnostics Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Lab Automation for In-Vitro Diagnostics Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.14. Iran
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.14.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.14.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.14.5. Iran Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.6.14.6. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.15. Qatar
      • 11.6.15.1. Overview
      • 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.15.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.15.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.15.5. Qatar Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.6.15.6. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.16. Rest of MEA
      • 11.6.16.1. Overview
      • 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.16.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.16.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.16.5. Rest of MEA Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
      • 11.6.16.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Lab Automation for In-Vitro Diagnostics Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Roche
    • 12.2.2. Abbott
    • 12.2.3. Siemens Healthineers
    • 12.2.4. Danaher Corporation
    • 12.2.5. Thermo Fisher Scientific
    • 12.2.6. Becton Dickinson and Company
    • 12.2.7. Agilent Technologies
    • 12.2.8. Bio-Rad Laboratories
    • 12.2.9. QIAGEN
    • 12.2.10. Tecan Group
    • 12.2.11. PerkinElmer
    • 12.2.12. Hamilton Company
    • 12.2.13. Illumina
    • 12.2.14. Sysmex Corporation
    • 12.2.15. Hudson Robotics
    • 12.2.16. Aurora Biomed
    • 12.2.17. Eppendorf
    • 12.2.18. Beckman Coulter
    • 12.2.19. Shimadzu Corporation
    • 12.2.20. Revvity
    • 12.2.21. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us